Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development
Registration link:
https://www.eventbrite.com/e/1021029977147?aff=oddtdtcreator
Date:
Wednesday, Oct 2nd, 2024; 11:00 am PST, or 2:00 pm EST
Webinar Highlights:
Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating their effectiveness in preclinical cancer research. The session will delve into the comprehensive use of gene-modified cell lines and genetically modified spontaneous mouse models, showcasing their application in mimicking human cancer biology. We will conclude with a brief introduction to our company and our commitment to accelerating cancer drug development through innovative animal modeling services.
This webinar is ideal for researchers, drug developers, and anyone involved in cancer therapy seeking to understand the latest advancements in tumor modeling.
Meet Our Speaker:
Dr. Juan (Jane) Hong earned her Bachelor's degree and Ph.D. from Nanjing Medical University in 2017, specializing in neuroinflammation and molecular biology related to central nervous system (CNS) diseases. She then furthered her research at the University of Nebraska and Washington University in St. Louis, dedicating six years to studying biomarkers across various diseases, with a particular focus on immuno-oncology. In 2022, Jane joined the International Industrial Client Department at GenoBioTX as a Senior Marketing Manager, where she has been involved in numerous projects evaluating small and large molecules in various cancer models. Her career has been marked by extensive experience in developing and assessing drug candidates in preclinical models.
About GenoBioTX
GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.
Contact us
Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
